Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$21.54 - $24.41 $689 - $781
-32 Reduced 15.69%
172 $3,000
Q2 2023

Aug 09, 2023

BUY
$12.62 - $24.47 $2,574 - $4,991
204 New
204 $4,000
Q2 2022

Aug 12, 2022

SELL
$12.69 - $19.25 $317 - $481
-25 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$17.38 - $21.54 $434 - $538
25 New
25 $1,000

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.